• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

μ-阿片受体激动剂和κ-阿片受体激动剂对小鼠尿量的影响。

Effects of mu- and kappa-opioid receptor agonists on urinary output in mice.

作者信息

Rathbun R C, Kattau R W, Leander J D

出版信息

Pharmacol Biochem Behav. 1983 Nov;19(5):863-6. doi: 10.1016/0091-3057(83)90094-1.

DOI:10.1016/0091-3057(83)90094-1
PMID:6316374
Abstract

The effects of ethylketazocine, morphine, bremazocine and naloxone were determined on urinary output and weight loss in Cox mice. Morphine and fentanyl were also studied in Harlan mice. Bremazocine, ethylketazocine and morphine markedly increased urinary output and weight loss within 5 hr after injection. Naloxone antagonized the diuretic actions of morphine (5 mg/kg) and bremazocine (0.06 mg/kg) over a similar dose range (0.3--10 mg/kg). By comparison with the other agonists, fentanyl had little effect on urinary output or weight loss. These results suggest that kappa agonist activity increases urinary output in mice just as reported for rats. The data also suggest that in mice morphine has some kappa agonist activity, whereas fentanyl does not.

摘要

研究了乙基酮佐辛、吗啡、布瑞马佐辛和纳洛酮对考克斯小鼠尿量和体重减轻的影响。还在哈兰小鼠中研究了吗啡和芬太尼。布瑞马佐辛、乙基酮佐辛和吗啡在注射后5小时内显著增加尿量和体重减轻。纳洛酮在相似剂量范围(0.3 - 10mg/kg)内拮抗吗啡(5mg/kg)和布瑞马佐辛(0.06mg/kg)的利尿作用。与其他激动剂相比,芬太尼对尿量或体重减轻几乎没有影响。这些结果表明,κ激动剂活性可增加小鼠尿量,正如在大鼠中所报道的那样。数据还表明,在小鼠中吗啡具有一定的κ激动剂活性,而芬太尼则没有。

相似文献

1
Effects of mu- and kappa-opioid receptor agonists on urinary output in mice.μ-阿片受体激动剂和κ-阿片受体激动剂对小鼠尿量的影响。
Pharmacol Biochem Behav. 1983 Nov;19(5):863-6. doi: 10.1016/0091-3057(83)90094-1.
2
Discriminative stimulus properties of U50,488 and morphine: effects of training dose on stimulus substitution patterns produced by mu and kappa opioid agonists.U50,488与吗啡的辨别性刺激特性:训练剂量对μ和κ阿片类激动剂产生的刺激替代模式的影响
J Pharmacol Exp Ther. 1990 Jul;254(1):13-22.
3
Discriminative stimulus effects of mu and kappa opioids in the pigeon: analysis of the effects of full and partial mu and kappa agonists.μ和κ阿片类药物对鸽子的辨别性刺激作用:μ和κ完全激动剂与部分激动剂作用的分析
J Pharmacol Exp Ther. 1989 May;249(2):557-66.
4
Further study of kappa opioids on increased urination.对κ阿片类药物增加排尿作用的进一步研究。
J Pharmacol Exp Ther. 1983 Oct;227(1):35-41.
5
A kappa opioid effect: increased urination in the rat.κ阿片样物质效应:大鼠尿量增加。
J Pharmacol Exp Ther. 1983 Jan;224(1):89-94.
6
Delineation of mu-antagonist, partial kappa agonist and non-opioid agonist activity of cyclazocine using urinary output of rats.利用大鼠尿量描绘环唑辛的μ-拮抗剂、部分κ-激动剂和非阿片类激动剂活性
Pharmacol Biochem Behav. 1987 Apr;26(4):705-7. doi: 10.1016/0091-3057(87)90600-9.
7
Differential cross-tolerance to mu and kappa opioid agonists in morphine-tolerant rats responding under a schedule of food presentation.在按食物呈现时间表做出反应的吗啡耐受大鼠中,对μ和κ阿片受体激动剂的差异性交叉耐受性。
Psychopharmacology (Berl). 1991;103(1):129-35. doi: 10.1007/BF02244087.
8
Kappa opioid agonists and antagonists: effects on drinking and urinary output.κ阿片受体激动剂和拮抗剂:对饮水及尿量的影响。
Appetite. 1984 Mar;5(1):7-14. doi: 10.1016/s0195-6663(84)80044-6.
9
Agonist and antagonist activity of kappa opioids in the squirrel monkey: I. Antinociception and urine output.松鼠猴中κ阿片类药物的激动剂和拮抗剂活性:I. 抗伤害感受和尿量
J Pharmacol Exp Ther. 1992 Jan;260(1):327-33.
10
Kappa-opiates and urination: pharmacological evidence for an endogenous role of the kappa-opiate receptor in fluid and electrolyte balance.κ-阿片类药物与排尿:κ-阿片受体在体液和电解质平衡中内源性作用的药理学证据。
Eur J Pharmacol. 1984 Dec 15;107(1):1-10. doi: 10.1016/0014-2999(84)90084-0.

引用本文的文献

1
Kappa Opioid Receptor Agonist and Brain Ischemia.κ阿片受体激动剂与脑缺血
Transl Perioper Pain Med. 2014;1(2):27-34.
2
Comparison of the diuretic effects of chemically diverse kappa opioid agonists in rats: nalfurafine, U50,488H, and salvinorin A.化学结构各异的κ阿片受体激动剂在大鼠体内的利尿作用比较:纳呋拉啡、U50,488H和Salvinorin A。
Naunyn Schmiedebergs Arch Pharmacol. 2009 Mar;379(3):263-70. doi: 10.1007/s00210-008-0358-8. Epub 2008 Oct 17.